FOXA2-mediated GDF15 secretion drives metastasis and CD8+ T cell exhaustion in clear cell renal cell carcinoma
Journal of Clinical Investigation · 19.11.2026
DOI: 10.1172/jci198580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 19.11.2026. Verfasst von Cong Huang und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Despite recent therapeutic advances, the prognosis of patients with metastatic clear cell renal cell carcinoma (ccRCC) remains poor, and the molecular mechanisms driving metastasis are not fully understood. Herein, we identify forkhead box transcription factor A2 (FOXA2) as a key regulator of ccRCC metastasis. FOXA2 expression is elevated in metastatic ccRCC and correlates with adverse clinical outcomes. Functional assays show that FOXA2 enhances ccRCC cell invasion and metastasis both in vitro and in vivo. Mechanistically, FOXA2 recruits the histone acetyltransferase HAT1 as a transcriptional coactivator to upregulate growth differentiation factor 15 (GDF15) expression, which in turn activates GFRAL/RET-mediated STAT3 signaling and the epithelial-to-mesenchymal transition (EMT), thereby driving metastasis through both autocrine and paracrine pathways. Moreover, tumor cell-secreted GDF15 facilitates CD8 + T cell exhaustion within the tumor microenvironment, contributing to immune evasion and resistance to anti-PD-1 therapy. Importantly, pharmacologic inhibition of this pathway using either the GDF15-neutralizing antibody ponsegromab or the RET inhibitor pralsetinib markedly impairs FOXA2-driven metastasis and synergizes with anti-PD-1 therapy. Together, our findings delineate a FOXA2–GDF15–STAT3 signaling axis that orchestrates metastatic progression and immune suppression in ccRCC and suggest promising therapeutic strategies for patients with advanced disease.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Huang, C., Rui, R., Guo, H., He, A., Gao, W., Fan, J., Zhang, C., Gong, Y., Zhou, L., Li, X., & He, S. (2026). FOXA2-mediated GDF15 secretion drives metastasis and CD8+ T cell exhaustion in clear cell renal cell carcinoma. Journal of Clinical Investigation. https://doi.org/10.1172/jci198580
Vancouver
Huang C, Rui R, Guo H, He A, Gao W, Fan J, et al. FOXA2-mediated GDF15 secretion drives metastasis and CD8+ T cell exhaustion in clear cell renal cell carcinoma. Journal of Clinical Investigation. 2026. doi:10.1172/jci198580
BibTeX
@article{Huang2026,
author = {Huang, Cong and Rui, Rui and Guo, Heng and He, Anbang and Gao, Wenzhi and Fan, Jian and Zhang, Cuijian and Gong, Yanqing and Zhou, Liqun and Li, Xuesong and He, Shiming},
title = {FOXA2-mediated GDF15 secretion drives metastasis and CD8+ T cell exhaustion in clear cell renal cell carcinoma},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci198580}
}
EUVIMED